Attovia Therapeutics ATTO
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$911.7K (4 inflow days, 16 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 42.8% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 1.19% to 3.48% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Charles Schwab Investment Management | Mutual Fund | 2026/Q3 | +100,603 | 0.2% |
| Sanofi | Public Company | 2026/Q3 | +1,082,855 | 2.4% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +782,012 | 1.7% |
| Federated Hermes, Inc. | Mutual Fund | 2026/Q3 | +700,000 | 1.5% |
| FMR | Mutual Fund | 2026/Q3 | +323,669 | 0.7% |
| BlackRock | Mutual Fund | 2026/Q3 | +265,397 | 0.6% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +206,176 | 0.5% |
| UBS Asset Management | Mutual Fund | 2026/Q3 | +183,751 | 0.4% |
| Squarepoint OPS LLC | Hedge Fund | 2026/Q3 | +42,725 | 0.1% |
| Morgan Stanley Investment Management Inc. | Mutual Fund | 2026/Q3 | +38,451 | 0.1% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +20,495 | 0.0% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +90,644 | 0.2% |
| Hartford Funds Management Company, LLC | Mutual Fund | 2026/Q3 | +12,400 | 0.0% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +2,430 | 0.0% |
| Wellington Management Group | Mutual Fund | 2026/Q3 | +1,800 | 0.0% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 5 Aug 2026 | Sanofi | Private Acquisition | +300,000 | $17.00 | 1,082,855 | |
| 5 Aug 2026 | Sanofi | Derivative Exercise and Retained | +782,855 | – | 1,082,855 | |
| 5 Aug 2026 | Redmile Group, LLC | Private Acquisition | +200,000 | $17.00 | 982,854 | |
| 5 Aug 2026 | Redmile Group, LLC | Derivative Exercise and Retained | +782,854 | – | 982,854 | |
| 5 Aug 2026 | venBio LLC | Private Acquisition | +382,352 | $17.00 | 4,181,367 | |
| 5 Aug 2026 | venBio LLC | Derivative Exercise and Retained | +3,799,015 | – | 4,181,367 | |
| 5 Aug 2026 | Deep Track Capital, LP | Derivative Exercise and Retained | +1,957,138 | – | 1,957,138 | |
| 5 Aug 2026 | Frazier Life Sciences Management, LP | Private Acquisition | +588,235 | $17.00 | 6,154,213 | |
| 5 Aug 2026 | Frazier Life Sciences Management, LP | Derivative Exercise and Retained | +5,490,629 | – | 6,154,213 | |
| 4 Aug 2026 | The Goldman Sachs Group, Inc. | Intent to Sell (Form 144) | -105,807 | $21.00 | – | |
| 4 Aug 2026 | Goldman Sachs Asset Management, L.P. | Open Market Derivative Acquisiti | +105,807 | – | 105,807 | |
| 3 Aug 2026 | Sanofi | Initial Statement of Beneficial | +0 | – | 782,855 | |
| 3 Aug 2026 | Mitchell Gold | Independent Director | Other Derivative Acquisition | +27,000 | $17.00 | 27,000 |
| 3 Aug 2026 | Mitchell Gold | Independent Director | Initial Statement of Beneficial | +0 | – | 19,913 |
| 3 Aug 2026 | Angie You | Independent Director | Other Derivative Acquisition | +27,000 | $17.00 | 27,000 |
| 3 Aug 2026 | John Smither | Independent Director | Initial Statement of Beneficial | +0 | – | 72,792 |
| 3 Aug 2026 | Hubert Chen | Chief Medical Officer | Other Derivative Acquisition | +140,000 | $17.00 | 140,000 |
| 3 Aug 2026 | Broad Street Principal Investments, L.L.C. | Initial Statement of Beneficial | +0 | – | 855,179 | |
| 3 Aug 2026 | Tao Fu | Chief Executive Officer | Other Derivative Acquisition | +538,300 | $17.00 | 538,300 |
| 3 Aug 2026 | Tao Fu | Chief Executive Officer | Initial Statement of Beneficial | +0 | – | 803,436 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 1,587,537 | 3.5% | 4.5 |
| 15 Oct 2026 | 1,453,089 | 3.2% | 3.5 |
| 30 Sep 2026 | 1,649,612 | 3.6% | 3.0 |
| 15 Sep 2026 | 831,090 | 1.8% | 4.0 |
| 31 Aug 2026 | 648,541 | 1.5% | 3.1 |
| 14 Aug 2026 | 511,865 | 1.2% | 1.0 |
No comments yet — be the first to weigh in on ATTO.
Sign in to join the discussion.